1,155 Shares in CME Group Inc. (NASDAQ:CME) Acquired by Flossbach Von Storch SE

Flossbach Von Storch SE purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,155 shares of the financial services provider's stock, valued at approximately $306,000.

A number of other large investors have also modified their holdings of CME. SeaCrest Wealth Management LLC boosted its position in shares of CME Group by 3.0% during the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after purchasing an additional 40 shares during the period. New Age Alpha Advisors LLC raised its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Wealthcare Advisory Partners LLC raised its holdings in shares of CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after purchasing an additional 47 shares in the last quarter. Koshinski Asset Management Inc. grew its position in shares of CME Group by 1.4% in the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock valued at $934,000 after buying an additional 48 shares during the last quarter. Finally, Berry Wealth Group LP grew its position in shares of CME Group by 0.4% in the 1st quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock valued at $3,598,000 after buying an additional 49 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CME shares. Morgan Stanley lifted their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. Barclays raised their price target on CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a research note on Thursday. Piper Sandler raised their target price on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Bank of America lifted their price objective on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Finally, Wall Street Zen upgraded CME Group from a "sell" rating to a "hold" rating in a report on Saturday, July 5th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $260.93.

CME Group Price Performance

Shares of CME traded down $0.11 during midday trading on Friday, reaching $275.08. The stock had a trading volume of 1,531,570 shares, compared to its average volume of 2,194,464. The firm's 50 day moving average price is $276.69 and its 200-day moving average price is $258.98. The company has a market capitalization of $99.13 billion, a P/E ratio of 27.67, a P/E/G ratio of 3.74 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52 week low of $193.17 and a 52 week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the firm earned $2.50 earnings per share. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's payout ratio is currently 50.30%.

Insider Buying and Selling

In other CME Group news, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the sale, the insider owned 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Charles P. Carey sold 3,000 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the sale, the director directly owned 5,400 shares in the company, valued at $1,471,824. This trade represents a 35.71% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,400 shares of company stock worth $3,680,610. Insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.